Ultragenyx Pharmaceutical Inc.
RARE
$23.40
$0.652.86%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.78% | -1.39% | -18.95% | 0.41% | -20.46% |
| Total Receivables | -8.65% | 23.85% | -16.80% | 29.97% | -12.17% |
| Inventory | 12.26% | 1.01% | 2.28% | 3.86% | 7.97% |
| Prepaid Expenses | -19.71% | 4.09% | 49.50% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.75% | 6.58% | 24.55% | -87.32% | 2.41% |
| Total Current Assets | -10.64% | 2.95% | -14.44% | 2.19% | -17.11% |
|
|
|||||
| Total Current Assets | -10.64% | 2.95% | -14.44% | 2.19% | -17.11% |
| Net Property, Plant & Equipment | -2.27% | -1.97% | -10.47% | 6.97% | -2.25% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -1.02% | -1.01% | -1.00% | 8.11% | -0.78% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -3.76% | -3.61% | 67.76% | -30.99% | 0.19% |
| Total Assets | -8.87% | -0.43% | -12.74% | -2.27% | -4.95% |
|
|
|||||
| Total Accounts Payable | 18.49% | -27.84% | 22.43% | 7.69% | -39.82% |
| Total Accrued Expenses | 21.98% | 4.50% | -28.20% | 30.24% | 19.82% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.72% | 11.44% | 12.83% | 1.67% | 0.88% |
| Total Finance Division Other Current Liabilities | -52.11% | -22.91% | -21.78% | -11.48% | -- |
| Total Other Current Liabilities | -52.11% | -22.91% | -21.78% | -11.48% | -- |
| Total Current Liabilities | 15.95% | 0.54% | -15.25% | 20.75% | 4.45% |
|
|
|||||
| Total Current Liabilities | 15.95% | 0.54% | -15.25% | 20.75% | 4.45% |
| Long-Term Debt | -2.43% | -1.42% | -3.14% | -1.19% | -1.48% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -11.58% | -11.71% | -7.51% | 26.99% | -8.10% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.91% | 0.58% | 0.09% | 2.07% | 2.06% |
| Total Liabilities | 2.29% | -1.09% | -6.48% | 4.78% | -0.13% |
|
|
|||||
| Common Stock & APIC | 0.85% | 2.87% | 0.94% | 1.04% | 1.11% |
| Retained Earnings | -4.27% | -2.80% | -3.82% | -3.49% | -3.62% |
| Treasury Stock & Other | 405.97% | 21.41% | 46.97% | -171.76% | 181.83% |
| Total Common Equity | -93.95% | 4.88% | -43.50% | -26.39% | -19.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -93.95% | 4.88% | -43.50% | -26.39% | -19.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Equity | -89.79% | 4.65% | -42.34% | -25.87% | -18.17% |
|
|
|||||